Evidence map›Paper›PMID 39890418›Full record

ArticleBMJ case reports2025

Oesophageal adenocarcinoma presenting with synchronous brain metastases.

Derek Petrosian, Camilo E Fadul, Matthew Reilley, Patrick Dillon

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Derek PetrosianDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Camilo E FadulDepartment of Neurology, University of Virginia, Charlottesville, Virginia, USA.
Matthew ReilleyUniversity of Virginia, Charlottesville, Virginia, USA.
Patrick DillonDepartment of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA pmd5b@hscmail.mcc.virginia.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain metastases are rare and poorly understood complications of oesophageal carcinoma. This report describes a case of brain metastasis as the initial presentation of oesophageal adenocarcinoma. The rarity and the lack of prospective clinical trials of brain metastasis in oesophageal cancer result in the absence of treatment guidelines. Common treatments for brain metastases, regardless of tumour of origin, are applicable to oesophageal brain metastases and include surgical resection, whole brain radiation therapy, stereotactic radiosurgery, chemotherapy/immunotherapy and/or symptomatic control with steroids and anticonvulsants.

Indexed as

AdenocarcinomaBrain NeoplasmsEsophageal NeoplasmsHumansNeurooncologyOesophageal cancerRadiology

Identifiers

PMID39890418
PMCPMC11791889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.